Home The Word Brain Fast Track My Amedeo FAQ About Flying Publisher   

Fast Track

Ear2MemoryFree App | Free PDF | Web
Learning languages on your smartphone

Free Abstracts

  Gastric Cancer

  Free Subscription


1 Am J Clin Oncol
1 Am J Clin Pathol
1 Anticancer Res
1 Cancer Lett
1 Clin Res Hepatol Gastroenterol
1 Dig Dis Sci
1 Gastroenterology
1 Gut
1 Int J Oncol
7 Oncol Rep

  Retrieve available abstracts of this week’s articles:
HTML format
Text format
Single Articles

    Am J Clin Oncol

  1. LIU Y, Zhao G, Xu Y, Zhang T, et al
    Phase II Study of Adjuvant Chemoradiotherapy Using Docetaxel/Cisplatin/5-Fluorouracil Before and After Intensity-modulated Radiotherapy With Concurrent Docetaxel in Patients With Completely (R0) Resected Gastric Carcinoma.
    Am J Clin Oncol. 2017 Mar 3. doi: 10.1097/COC.0000000000000373.
    PubMed     Text format     Abstract available

    Am J Clin Pathol

  2. LIN C, Zhang Z, Xu Y, Wang R, et al
    High Tumor Vascular Endothelial Growth Factor Expression Is Associated With Poorer Clinical Outcomes in Resected T3 Gastric Adenocarcinoma.
    Am J Clin Pathol. 2016;146:278-88.
    PubMed     Text format     Abstract available

    Anticancer Res

  3. PROUET P, Giri S, Wiedower E, Fintel A, et al
    Addition of Rituximab to Chemotherapy Reduced the Rate of Surgery for Gastric-DLBCL Without Increasing Early Mortality.
    Anticancer Res. 2017;37:813-817.
    PubMed     Text format     Abstract available

    Cancer Lett

  4. LI Y, Wu Z, Yuan J, Sun L, et al
    Long non-coding RNA MALAT1 promotes gastric cancer tumorigenicity and metastasis by regulating vasculogenic mimicry and angiogenesis.
    Cancer Lett. 2017 Mar 4. pii: S0304-3835(17)30152.
    PubMed     Text format     Abstract available

    Clin Res Hepatol Gastroenterol

  5. FU X, Xie W, Song X, Wu K, et al
    Aberrant expression of deubiquitylating enzyme USP9X predicts poor prognosis in gastric cancer.
    Clin Res Hepatol Gastroenterol. 2017 Mar 5. pii: S2210-7401(17)30043.
    PubMed     Text format     Abstract available

    Dig Dis Sci

  6. LI T, Meng XL, Yang WQ
    Long Noncoding RNA PVT1 Acts as a "Sponge" to Inhibit microRNA-152 in Gastric Cancer Cells.
    Dig Dis Sci. 2017 Mar 3. doi: 10.1007/s10620-017-4508.
    PubMed     Text format     Abstract available


    Gaining Ground in the Genetics of Gastric Cancer.
    Gastroenterology. 2017 Feb 28. pii: S0016-5085(17)30213.
    PubMed     Text format    


  8. WANG TT, Zhao YL, Peng LS, Chen N, et al
    Tumour-activated neutrophils in gastric cancer foster immune suppression and disease progression through GM-CSF-PD-L1 pathway.
    Gut. 2017 Mar 8. pii: gutjnl-2016-313075. doi: 10.1136/gutjnl-2016-313075.
    PubMed     Text format     Abstract available

    Int J Oncol

  9. SHEN L, Luo Z, Wu J, Qiu L, et al
    Enhanced expression of alpha2,3-linked sialic acids promotes gastric cancer cell metastasis and correlates with poor prognosis.
    Int J Oncol. 2017 Feb 20. doi: 10.3892/ijo.2017.3882.
    PubMed     Text format     Abstract available

    Oncol Rep

  10. BU X, Li M, Zhao Y, Liu S, et al
    Genetically engineered Newcastle disease virus expressing human interferon-lambda1 induces apoptosis in gastric adenocarcinoma cells and modulates the Th1/Th2 immune response.
    Oncol Rep. 2016;36:1393-402.
    PubMed     Text format     Abstract available

  11. TAMAKI R, Kanai-Mori A, Morishige Y, Koike A, et al
    Effects of 5-fluorouracil, adriamycin and irinotecan on HSC-39, a human scirrhous gastric cancer cell line.
    Oncol Rep. 2017 Feb 20. doi: 10.3892/or.2017.5470.
    PubMed     Text format     Abstract available

  12. LIU Y, Sun Y, Zhao A
    MicroRNA-134 suppresses cell proliferation in gastric cancer cells via targeting of GOLPH3.
    Oncol Rep. 2017 Mar 2. doi: 10.3892/or.2017.5488.
    PubMed     Text format     Abstract available

  13. WANG L, Huang X, Chai Y, Zou L, et al
    Octreotide inhibits the proliferation of gastric cancer cells through P300-HAT activity and the interaction of ZAC and P300.
    Oncol Rep. 2017 Feb 14. doi: 10.3892/or.2017.5451.
    PubMed     Text format     Abstract available

  14. SUN DP, Fang CL, Chen HK, Wen KS, et al
    EPAC1 overexpression is a prognostic marker and its inhibition shows promising therapeutic potential for gastric cancer.
    Oncol Rep. 2017 Feb 14. doi: 10.3892/or.2017.5442.
    PubMed     Text format     Abstract available

  15. WANG J, Zhou Y, Fei X, Chen X, et al
    ADAM9 functions as a promoter of gastric cancer growth which is negatively and post-transcriptionally regulated by miR-126.
    Oncol Rep. 2017 Feb 16. doi: 10.3892/or.2017.5460.
    PubMed     Text format     Abstract available

  16. HUANG Y, Li X, Sha H, Zhang L, et al
    Tumor-penetrating peptide fused to a pro-apoptotic peptide facilitates effective gastric cancer therapy.
    Oncol Rep. 2017 Feb 10. doi: 10.3892/or.2017.5440.
    PubMed     Text format     Abstract available

Thank you for your interest in scientific medicine.

AMEDEO Gastric Cancer is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.